Medtronic plc
MDT
Xếp hạng trong cổ phiếu
#184
Medtronic plc is a leading global medical technology enterprise that invents,... Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
Giá cổ phiếu
$94.59
Đồng bộ lần cuối: 2026-10-20
Vốn hóa thị trường
$120.99B
Thay đổi (1 ngày)
1.76%
Thay đổi (1 năm)
-1.30%
Quốc gia
IE
Giao dịch Medtronic plc (MDT)
Danh mục
Healthcare
Doanh thu của Medtronic plc (MDT)
Doanh thu vào Jan 2026 TTM: $35.48B
Theo các báo cáo tài chính gần đây của Medtronic plc, doanh thu hiện tại của công ty (TTM) là $35.48B. Trong năm 2024, công ty đạt doanh thu $32.36B tăng so với doanh thu năm 2023, là $31.23B. Doanh thu là tổng số tiền công ty tạo ra từ việc bán hàng hóa hoặc dịch vụ. Không giống như lợi nhuận, doanh thu không trừ chi phí.
Lịch sử doanh thu của Medtronic plc từ 2000 đến 2026
Doanh thu vào cuối mỗi năm
| Năm | Doanh thu | Thay đổi |
|---|---|---|
| 2026 (TTM) | $35.48B | 5.81% |
| 2025 | $33.54B | 3.62% |
| 2024 | $32.36B | 3.64% |
| 2023 | $31.23B | -1.45% |
| 2022 | $31.69B | 5.21% |
| 2021 | $30.12B | 4.16% |
| 2020 | $28.91B | -5.38% |
| 2019 | $30.56B | 2.02% |
| 2018 | $29.95B | 0.82% |
| 2017 | $29.71B | 3.04% |
| 2016 | $28.83B | 42.31% |
| 2015 | $20.26B | 19.15% |
| 2014 | $17.01B | 2.50% |
| 2013 | $16.59B | 2.51% |
| 2012 | $16.18B | 1.58% |
| 2011 | $15.93B | 0.73% |
| 2010 | $15.82B | 8.34% |
| 2009 | $14.60B | 8.02% |
| 2008 | $13.52B | 9.89% |
| 2007 | $12.30B | 8.92% |
| 2006 | $11.29B | 12.31% |
| 2005 | $10.05B | 10.65% |
| 2004 | $9.09B | 18.55% |
| 2003 | $7.67B | 19.57% |
| 2002 | $6.41B | 15.47% |
| 2001 | $5.55B | 10.71% |
| 2000 | $5.01B | 0.00% |
Doanh thu của các công ty hoặc đối thủ tương tự
| Công ty | Doanh thu | Chênh lệch doanh thu | Quốc gia |
|---|---|---|---|
| $46.59B | 31.28% |
US
|
|
| $25.84B | -27.19% |
US
|
|
| $21.00B | -40.83% |
US
|
|
| - | - |
DE
|
|
| $6.51B | -81.65% |
US
|
